This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Matthew Raybould, Ph.D.
Postdoctoral Researcher at University of Oxford


Dr. Matthew Raybould has an MChem in Chemistry and a PhD in Immunoinformatics from the University of Oxford. His PhD focused on the development of 3D structure-aware computational tools for antibody drug discovery and development, and was conducted in the Oxford Protein Informatics Group (OPIG) under the supervision of Professor Charlotte Deane. Matthew continues to work in OPIG as a postdoctoral researcher, performing and supervising computational analyses of adaptive immune receptor repertoires and methodology development for in silico-assisted immunotherapy/vaccine design.

Matthew Raybould, Ph.D.'s Network

Agenda Sessions

  • The Second-Generation Therapeutic Antibody Profiler for Computational Developability Triaging and Rational Design